News Story

Zhang Lab members present at the 13th Annual McNair Symposium

At the 13th Annual McNair Symposium on April 14, 2026, Dr. Bing Zhang, PI of Zhang Lab, delivered a talk, and Yanling Sun and Moran Chen presented posters.

On April 14, 2026, members of Zhang Lab shared their latest research at the 13th Annual McNair Symposium.

Dr. Bing Zhang, principal investigator of Zhang Lab, presented a talk titled “Uncovering Hidden Tumor Antigens for Precision Immunotherapy.”

Dr. Yanling Sun presented a poster titled “PTMax: An AI-enabled platform integrating literature mining and multi-omics for functional interpretation of phosphorylation in cancer.”

Dr. Moran Chen presented a poster titled “Two-Way Proteogenomics Identifies Tumor-Specific, Immune-Visible Peptides for Immunotherapy Development in Triple-Negative Breast Cancer.”

The symposium provided a great opportunity to highlight the lab’s work in precision immunotherapy, phosphoproteomics, and cancer proteogenomics.

Congratulations to Dr. Zhang for presenting the lab’s broader research vision in precision immunotherapy, and to Drs. Sun and Chen for sharing their work through poster presentations.

Dr. Bing Zhang speaking with another attendee at the 13th Annual McNair Symposium
Dr. Bing Zhang with a fellow attendee during the symposium.
Title slide for Dr. Bing Zhang's talk at the 13th Annual McNair Symposium
Title slide for Dr. Zhang's talk, "Uncovering Hidden Tumor Antigens for Precision Immunotherapy."
A slide from Dr. Bing Zhang's McNair Symposium talk reflecting on a decade of discovery
A slide from Dr. Zhang's talk reflecting on a decade of discovery as a McNair Scholar.
Dr. Yanling Sun standing beside her poster at the 13th Annual McNair Symposium
Dr. Yanling Sun with her poster on PTMax, an AI-enabled platform for phosphorylation analysis in cancer.
Dr. Moran Chen standing beside his poster at the 13th Annual McNair Symposium
Dr. Moran Chen with his poster on tumor-specific, immune-visible peptides for immunotherapy development in triple-negative breast cancer.